Scribe Therapeutics Inc.
33.90
-0.00% (최근 종가 33.90)
Company profile — from Yahoo Finance
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.
Company information as provided by Yahoo Finance. Check the official filings before relying on it.
Market Cap
5억 달러
PER
-
Trailing 12 months
Forward P/E
-9.8배
Forward estimates
ROE
-
Return on equity
Dividend Yield
-
Beta
-
Volatility vs market
52주 범위에서 74% 지점입니다. 100%에 가까울수록 1년 최고가 부근입니다.
Source: Yahoo Finance
Average analyst price target
범위 $37.00 ~ $60.00 · 애널리스트 3명 · 종합의견 적극 매수 · 출처 Yahoo Finance
Analyst ratings: no data
Revenue trend
1억 달러
2024–2025 회계연도 · 축 단위는 달러입니다.
Net income trend
-0억 달러
2024–2025 회계연도 · 축 단위는 달러입니다.
| Year | Revenue | Operating Income | Net Income | Operating Cash Flow | Net Margin |
|---|---|---|---|---|---|
| 2025 | 1억 달러 | -0억 달러 | -0억 달러 | -0억 달러 | -42.6% |
| 2024 | 0억 달러 | -0억 달러 | -0억 달러 | -0억 달러 | -174.3% |
회계연도 기준 실적입니다(달력 연도와 다를 수 있습니다). 출처: Yahoo Finance. 값이 없는 항목은 채우지 않고 "-"로 둡니다.
Benzinga · 08. 24.
Benzinga · 08. 20.
Benzinga · 08. 20.
Prices, key stats, price targets, annual financials, filings and news above come straight from Yahoo Finance · Finnhub · SEC EDGAR, so they look the same for any US-listed ticker.
Support & resistance shows above whenever my TradingView indicator is sending alerts for the ticker. No alert is set up for this one yet, so there are no levels.
Option levels · MJM Score · REAL_BUY signals come through a Google Sheet and are still limited to the fixed watchlist. We leave them out rather than guess.
